Predicting outcomes after heated chemotherapy for stomach or colon spread
Part of Cancer, Digestive system clinical trials.
This study tries to better predict how well patients do after heated chemotherapy placed in the abdomen during surgery for stomach or colon cancer that has spread to the lining of the abdomen. It may help doctors choose the best treatment plan and timing for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stomach, gastroesophageal junction, colon, or rectal cancer with spread on the abdominal lining (peritoneal metastasis).
- During surgery, doctors must confirm the cancer is on the abdominal lining using tissue samples (biopsy/histology).
- Your tumor spread in the abdomen must be limited (PCI ≤ 15 for stomach; ≤ 20 for colon/rectum).
- The surgeon must be able to remove the abdominal lining cancer completely or almost completely (CCS 0–1) with a curative-intent operation.
- You must be well enough for surgery and heated chemotherapy (HIPEC), with no major heart problems or other surgery/HIPEC blockers.
- You must not have cancer spread to organs that can’t be removed (non-resectable distant metastases), and you must not be planning pregnancy during the treatment window.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at samples of blood and tissue from people with advanced stomach cancer that has spread to the belly lining. The goal is to find markers that predict how well a treatment combining HIPEC (heated chemotherapy in the belly) with immunotherapy (drugs that help your immune system fight cancer) works.
This trial compares standard laparoscopic surgery for stomach cancer versus the same surgery plus HIPEC, which is heated chemotherapy placed in the abdomen during the operation. It aims to see if adding the heated chemotherapy improves outcomes for people with higher-stage stomach cancer.
This trial tests whether adding heated chemotherapy to the belly right after surgery can help people with stomach cancer live longer. It is done during the same operation, aiming to kill any remaining cancer cells.
This Phase 3 trial studies whether adding a heated chemotherapy procedure during surgery (HIPEC) before the main cancer treatment can lower the chance that stomach cancer returns in the belly. It is for people with advanced stomach cancer who are at higher risk of cancer coming back in the peritoneum (the lining of the abdomen).
This trial combines heated chemotherapy directly into the abdomen (HIPEC) with standard chemotherapy and an immunotherapy drug to treat advanced stomach cancer that has spread to the lining of the abdomen. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial studies a combination treatment for stomach cancer that has spread to the lining of the abdomen. It uses a special way to deliver heated chemotherapy directly into the abdomen, along with an immunotherapy drug that helps your immune system attack the cancer.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.